 Delayed onset cardiac arrhythmias sustained-release verapamil Sustained-release products overdose prolonged effects onset availability sustained-release calcium channel blockers initial misleading picture patients risk serious toxicity cases adults onset arrhythmias ingestion sustained-release verapamil cases single dose activated charcoal patients toxicity unique problems sustained-release formulations cardiac monitoring sustained-release calcium channel blocker possible early asymptomatic period